Related Experiment Video

Updated: Oct 19, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Natural history of hepatitis C in HIV-negative patients with congenital coagulation disorders

K Meijer1, E B Haagsma, T Kok

  • 1Division of Haemostasis, Thrombosis and Rheology, University Hospital Groningen, The Netherlands. k.meijer@int.azg.nl

Journal of Hepatology
|September 17, 1999
PubMed

Insights

Hepatitis C (HCV) infection in HIV-negative patients with clotting disorders shows slow progression. After 19 years, most patients remained asymptomatic, but advanced age was a key risk factor for liver disease progression.

Area of Science:

  • Hepatology
  • Virology
  • Internal Medicine

Background:

  • Understanding hepatitis C natural history is crucial for patient counseling and treatment planning.
  • Data from unselected patient groups without comorbidities are needed.
  • This study focuses on HIV-negative patients with congenital coagulation defects, a homogeneous group without specific hepatitis C therapy.

Purpose of the Study:

  • To describe the natural history of hepatitis C infection.
  • To evaluate liver disease progression two decades post-infection.
  • To identify risk factors for advanced disease in a specific patient cohort.

Main Methods:

  • A cohort of 45 HCV-RNA positive, HIV-negative patients (primarily hemophiliacs) was studied.
  • Methods included medical history, physical examination, laboratory tests, and abdominal ultrasonography.
  • Patients were classified based on ultrasonography findings to assess liver disease severity.

Main Results:

  • After a median of 19 years, 58% showed only elevated transaminases, while 16% had cirrhosis on ultrasonography.
  • Only two patients experienced variceal bleeding; none had ascites.
  • Higher present age was identified as the primary independent risk factor for advanced liver disease.

Conclusions:

  • Hepatitis C progression is slow in this cohort, with most patients asymptomatic.
  • Liver cirrhosis was present in 16% of patients after two decades.
  • Increasing age is the main predictor of advanced liver disease in this population.
Abstract

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...